Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
| Hexabrix 320* : | |
| Type | Medicine Non Marketed |
| Originator | B |
| Agent | Intermedic |
| Distributor | Intermedic |
| Laboratory | Guerbet |
| Responsible Party | Guerbet |
| Origin | France |
| Manufacturer | Guerbet France |
| Origin | France |
| ATC | V08AB03 |
Hexabrix 320* :
Hexabrix 320* :
Hexabrix 320* :
Hexabrix 320* :
Hexabrix 320* :
| Hazard Level |
|---|
| ◼ Major |
| ◼ Moderate |
| ◼ Minor |
| ◼ Safe |
Hexabrix 320* :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Abdominal pain | Very rare |
| Agitation | Very rare |
| Amnesia | Very rare |
| Anaphylactic reactions | Not known |
| Anaphylactic shock | Not known |
| Anaphylactoid reactions | Not known |
| Angina pectoris | Very rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
| Anuria | Very rare |
| Arrhythmia | Very rare |
| Arthralgia (Pain joint) (Joint ache) | Very rare |
| Blindness transient (Temporary vision loss) | Very rare |
| Blood creatinine increased | Very rare |
| Bronchospasm | Very rare |
| Cardiac arrest | Very rare |
| Cephalea | Very rare |
| Chills | Not known |
| Circulatory collapse | Very rare |
| Coma | Very rare |
| Confusional state | Very rare |
| Convulsion | Very rare |
| Cough | Very rare |
| Diarrhoea (Diarrhea) | Very rare |
| Discomfort | Not known |
| Dyspnoea (dyspnea) | Very rare |
| Eczema | Very rare |
| Erythema | Very rare |
| Fever | Not known |
| Hallucination | Very rare |
| Hearing impaired | Very rare |
| Hypersalivation | Very rare |
| Hypersensitivity | Not known |
| Hypotension | Very rare |
| Injection site extravasation | Very rare |
| Injection site inflammation | Very rare |
| Injection site necrosis | Very rare |
| Injection site pain | Very rare |
| Joint effusion | Very rare |
| Laryngeal oedema | Very rare |
| Laryngospasm | Very rare |
| Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
| Maculopapular rash | Very rare |
| Malaise | Very rare |
| Myocardial infarction | Very rare |
| Nausea | Very rare |
| Paraesthesia (paresthesia) | Very rare |
| Paresis | Very rare |
| Parotid gland enlargement | Very rare |
| Pelvic pain | Very rare |
| Photophobia | Very rare |
| Presyncope | Not known |
| Pruritus | Very rare |
| Pulmonary oedema | Very rare |
| Redness | Not known |
| Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
| Respiratory insufficiency | Very rare |
| Sensation of heat (Feeling of warmth) (Sensation of warmth) | Very rare |
| Shakiness | Very rare |
| Sneezing excessive | Very rare |
| Somnolence | Very rare |
| Speech disorder | Very rare |
| Stevens-Johnson syndrome | Very rare |
| Syncope | Not known |
| Tachycardia | Very rare |
| Thrombophlebitis | Very rare |
| Thyroid disorder | Very rare |
| Torsade de pointes | Not known |
| Urticaria | Very rare |
| Ventricular fibrillation | Not known |
| Vertigo | Very rare |
| Visual disturbance | Very rare |
| Vomiting | Very rare |
Hexabrix 320* :
Different Units By MoH Code
Hexabrix 320* MoH 123 :
| Form | Injectable/rectal Solution |
| Packaging | Vial (Type II Glass) |
| Package Size | 50ml |
| Strength | 39.3g/19.65g/100ml |
| Storage Condition | <25°C protect from light |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 26626 |
| Submission date | 01/01/1989 |
| Registration Year | 1989 |
| Archived Date | 2018 |
Price Comparison
| ● Country: | Turkey | |
| ● Package Size: | 1x50ml | |
| ● Public Price: | 51.95 TRY | ( 139,226.00 LBP ) |
| ● Pack size unit used: | 1 | |
| ● Cost/Unit: | 51,95 TRY | ( 136,680.00 LBP ) |
| ● Pricing Date: | 28/10/2020 | |
| ● Type: | Medicine Authorised |
| ● Country: | Portugal |
| ● Package Size: | 50ml |
| ● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
| ● Pricing Date: | 22/04/2019 |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Hexabrix 320* MoH 122 :
| Form | Injectable/rectal Solution |
| Packaging | Vial (Type II Glass) |
| Package Size | 100ml |
| Strength | 39.3g/19.65g/100ml |
| Storage Condition | <25°C protect from light |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 26625 |
| Submission date | 01/01/1989 |
| Registration Year | 1989 |
| Archived Date | 2018 |
Price Comparison
| ● Country: | Switzerland | |
| ● Package Size: | 100ml | |
| ● Public Price: | 80.5 CHF | ( 8,325,310.00 LBP ) |
| ● Pack size unit used: | 1 | |
| ● Cost/Unit: | 80,5 CHF | ( 8,273,600.00 LBP ) |
| ● Exfactory Price: | 55.82 CHF | |
| ● Pricing Date: | 04/03/2020 | |
| ● Type: | Medicine Non Marketed |
| ● Country: | Turkey | |
| ● Package Size: | 100ml | |
| ● Public Price: | 100.59 TRY | ( 269,581.20 LBP ) |
| ● Pack size unit used: | 1 | |
| ● Cost/Unit: | 100,59 TRY | ( 268,000.00 LBP ) |
| ● Pricing Date: | 28/10/2020 | |
| ● Type: | Medicine Authorised |
| ● Country: | Portugal |
| ● Package Size: | 100ml |
| ● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
| ● Pricing Date: | 22/04/2019 |
| ● Country: | The Netherlands |
| ● Package Size: | 100ml |
| ● Reference: | Zorginstituut Nederland |
| ● Pricing Date: | 15/06/2019 |
| ● Type: | Medicine Non Marketed |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Hexabrix 320* MoH 124 :
| Form | Injectable/rectal Solution |
| Packaging | Vial (Type II Glass) |
| Package Size | 1x20ml |
| Strength | 39.3g/19.65g/100ml |
| Storage Condition | <25°C protect from light |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 26627 |
| Submission date | 01/01/1989 |
| Registration Year | 1989 |
| Archived Date | 2018 |
Price Comparison
| ● Country: | Portugal |
| ● Package Size: | 20ml |
| ● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
| ● Pricing Date: | 22/04/2019 |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
